Lista de obras -

Advances in the identification of γ-secretase inhibitors for the treatment of Alzheimer's disease.

artículo científico

Age-related hearing impairment and frailty in Alzheimer's disease: interconnected associations and mechanisms

artículo científico publicado en 2015

Alcohol consumption in mild cognitive impairment and dementia: harmful or neuroprotective?

artículo científico publicado en 2012

Alcohol drinking, cognitive functions in older age, predementia, and dementia syndromes

artículo científico publicado en 2009

Aluminum in the Diet and Alzheimer's Disease: From Current Epidemiology to Possible Disease-Modifying Treatment

scholarly article by Vincenza Frisardi et al published 24 March 2010 in Journal of Alzheimer's Disease

Aluminum in the diet and Alzheimer's disease: from current epidemiology to possible disease-modifying treatment

artículo científico publicado en 2010

Amyloid-based immunotherapy for Alzheimer's disease in the time of prevention trials: the way forward

artículo científico

Amyloid-directed monoclonal antibodies for the treatment of Alzheimer's disease: the point of no return?

artículo científico

Amyloid-related imaging abnormalities associated with immunotherapy in Alzheimer’s disease patients

Angiotensin-converting enzyme inhibitors and incidence of mild cognitive impairment. The Italian Longitudinal Study on Aging

artículo científico publicado en 2011

Anti-β-amyloid immunotherapy for Alzheimer's disease: focus on bapineuzumab

scientific article published on December 2011

Apolipoprotein E-related all-cause mortality in hospitalized elderly patients.

artículo científico publicado en 2010

Are NSAIDs useful to treat Alzheimer's disease or mild cognitive impairment?

artículo científico publicado en 2010

Association analysis of GRIN2B, encoding N-methyl-D-aspartate receptor 2B subunit, and Alzheimer's disease

artículo científico publicado en 2008

Author Correction: Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing

scientific article published on 01 September 2019

BACE inhibitors in clinical development for the treatment of Alzheimer's disease

article

Bapineuzumab: anti-β-amyloid monoclonal antibodies for the treatment of Alzheimer's disease.

artículo científico publicado en 2010

Beyond the neurotransmitter-focused approach in treating Alzheimer's disease: drugs targeting beta-amyloid and tau protein

artículo científico publicado en 2009

Coffee Consumption Habits and the Risk of Mild Cognitive Impairment: The Italian Longitudinal Study on Aging

artículo científico publicado en 2015

Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease

artículo científico publicado en 2011

Diet and Alzheimer’s disease risk factors or prevention: the current evidence

artículo científico publicado en 2011

Dietary unsaturated fatty acids and risk of mild cognitive impairment.

artículo científico publicado en 2010

Disease-modifying approach to the treatment of Alzheimer's disease: from alpha-secretase activators to gamma-secretase inhibitors and modulators.

artículo científico publicado en 2009

Efficacy and safety studies of gantenerumab in patients with Alzheimer's disease

artículo científico publicado en 2014

Emerging drugs to reduce abnormal β-amyloid protein in Alzheimer's disease patients.

artículo científico publicado en 2016

Evidence of the association of BIN1 and PICALM with the AD risk in contrasting European populations.

artículo científico publicado en 2011

Examination of level of knowledge in Italian general practitioners attending an education session on diagnosis and management of the early stage of Alzheimer's disease: pass or fail?

artículo científico publicado en 2016

Frailty syndrome and all-cause mortality in demented patients: the Italian Longitudinal Study on Aging ⬇️

artículo científico publicado el 26 de abril de 2011

Frailty syndrome and the risk of vascular dementia: the Italian Longitudinal Study on Aging

artículo científico publicado en 2012

Gene-wide analysis detects two new susceptibility genes for Alzheimer's disease

artículo científico publicado en 2014

Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing

artículo científico publicado en 2019

Immunotherapy for Alzheimer's disease: from anti-β-amyloid to tau-based immunization strategies.

artículo científico publicado en 2012

Interleukin 6-174 G/C promoter and variable number of tandem repeats (VNTR) gene polymorphisms in sporadic Alzheimer's disease.

artículo científico publicado en 2009

Is insulin resistant brain state a central feature of the metabolic-cognitive syndrome?

artículo científico publicado en 2010

Is there still any hope for amyloid-based immunotherapy for Alzheimer's disease?

artículo científico

Late-life depression, mild cognitive impairment, and dementia: possible continuum?

artículo científico publicado en 2010

Late-onset depression is associated to age-related central auditory processing disorder in an older population in Southern Italy

scientific article published on 31 October 2020

Lipoproteins, vascular-related genetic factors, and human longevity

artículo científico publicado en 2007

Metabolic syndrome and cognitive impairment: current epidemiology and possible underlying mechanisms

artículo científico publicado en 2010

Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer's disease

artículo científico publicado en 2010

Monoclonal antibodies against β-amyloid (Aβ) for the treatment of Alzheimer's disease: the Aβ target at a crossroads

artículo científico publicado en 2011

Neuropsychiatric Symptoms, Endophenotypes, and Syndromes in Late-Onset Alzheimer's Disease: Focus on APOE Gene.

artículo científico publicado en 2011

Non-apolipoprotein E and apolipoprotein E genetics of sporadic Alzheimer's disease

artículo científico publicado en 2009

Nutraceutical properties of Mediterranean diet and cognitive decline: possible underlying mechanisms.

artículo científico publicado en 2010

Nutrition, frailty, and Alzheimer's disease

artículo científico publicado en 2014

Peripheral antioxidant markers in mild cognitive impairment and its progression to dementia

artículo científico publicado en 2010

Polymorphism C in the serotonin transporter gene in depression-free elderly patients with vascular dementia

artículo científico publicado en 2010

Polymorphisms in glutathione S-transferase omega-1 gene and increased risk of sporadic Alzheimer disease

artículo científico publicado en 2010

Polyunsaturated fatty acid and S-adenosylmethionine supplementation in predementia syndromes and Alzheimer's disease: a review

artículo científico publicado en 2009

Postural and Balance Disorders in Patients with Parkinson's Disease: A Prospective Open-Label Feasibility Study with Two Months of Action Observation Treatment

artículo científico publicado en 2015

Progresses in treating agitation: a major clinical challenge in Alzheimer's disease

artículo científico

REVIEW: γ-Secretase inhibitors for the treatment of Alzheimer's disease: The current state.

artículo científico publicado en 2010

Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease

artículo científico publicado en 2017

Relationships of Dietary Patterns, Foods, and Micro- and Macronutrients with Alzheimer's Disease and Late-Life Cognitive Disorders: A Systematic Review.

artículo científico publicado en 2017

Reversible Cognitive Frailty, Dementia, and All-Cause Mortality. The Italian Longitudinal Study on Aging

artículo científico publicado en 2017

Role of CLU, PICALM, and TNK1 Genotypes in Aging With and Without Alzheimer's Disease

artículo científico publicado en 2017

Solanezumab for the treatment of mild-to-moderate Alzheimer's disease

artículo científico

Tau aggregation inhibitors: the future of Alzheimer's pharmacotherapy?

artículo científico publicado en 2016

Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer's Disease

artículo científico publicado en 2016

Tau-based therapeutics for Alzheimer's disease: active and passive immunotherapy

artículo científico publicado en 2016

Tau-directed approaches for the treatment of Alzheimer's disease: focus on leuco-methylthioninium

artículo científico publicado en 2016

The CALHM1 P86L polymorphism is a genetic modifier of age at onset in Alzheimer's disease: a meta-analysis study

artículo científico publicado en 2010

The Multidimensional Prognostic Index (MPI), based on a comprehensive geriatric assessment predicts short- and long-term mortality in hospitalized older patients with dementia

artículo científico publicado en 2009

The RELN Locus in Alzheimer's Disease

scholarly article by Davide Seripa et al published 11 June 2008 in Journal of Alzheimer's Disease

The RELN locus in Alzheimer's disease

artículo científico publicado en 2008

The potential of solanezumab and gantenerumab to prevent Alzheimer's disease in people with inherited mutations that cause its early onset

artículo científico publicado en 2017

Therapeutic intervention for Alzheimer's disease with γ-secretase inhibitors: still a viable option?

artículo científico publicado en 2011

Time to test antibacterial therapy in Alzheimer's disease

artículo científico publicado en 2019

Lista de obras de

Advances in the identification of γ-secretase inhibitors for the treatment of Alzheimer's disease.

Age-related hearing impairment and frailty in Alzheimer's disease: interconnected associations and mechanisms

Alcohol consumption in mild cognitive impairment and dementia: harmful or neuroprotective?

Alcohol drinking, cognitive functions in older age, predementia, and dementia syndromes

Aluminum in the Diet and Alzheimer's Disease: From Current Epidemiology to Possible Disease-Modifying Treatment

Aluminum in the diet and Alzheimer's disease: from current epidemiology to possible disease-modifying treatment

Amyloid-based immunotherapy for Alzheimer's disease in the time of prevention trials: the way forward

Amyloid-directed monoclonal antibodies for the treatment of Alzheimer's disease: the point of no return?

Amyloid-related imaging abnormalities associated with immunotherapy in Alzheimer’s disease patients

Angiotensin-converting enzyme inhibitors and incidence of mild cognitive impairment. The Italian Longitudinal Study on Aging

Anti-β-amyloid immunotherapy for Alzheimer's disease: focus on bapineuzumab

Apolipoprotein E-related all-cause mortality in hospitalized elderly patients.

Are NSAIDs useful to treat Alzheimer's disease or mild cognitive impairment?

Association analysis of GRIN2B, encoding N-methyl-D-aspartate receptor 2B subunit, and Alzheimer's disease

Author Correction: Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing

BACE inhibitors in clinical development for the treatment of Alzheimer's disease

Bapineuzumab: anti-β-amyloid monoclonal antibodies for the treatment of Alzheimer's disease.

Beyond the neurotransmitter-focused approach in treating Alzheimer's disease: drugs targeting beta-amyloid and tau protein

Coffee Consumption Habits and the Risk of Mild Cognitive Impairment: The Italian Longitudinal Study on Aging

Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease

Diet and Alzheimer’s disease risk factors or prevention: the current evidence

Dietary unsaturated fatty acids and risk of mild cognitive impairment.

Disease-modifying approach to the treatment of Alzheimer's disease: from alpha-secretase activators to gamma-secretase inhibitors and modulators.

Efficacy and safety studies of gantenerumab in patients with Alzheimer's disease

Emerging drugs to reduce abnormal β-amyloid protein in Alzheimer's disease patients.

Evidence of the association of BIN1 and PICALM with the AD risk in contrasting European populations.

Examination of level of knowledge in Italian general practitioners attending an education session on diagnosis and management of the early stage of Alzheimer's disease: pass or fail?

Frailty syndrome and all-cause mortality in demented patients: the Italian Longitudinal Study on Aging ⬇️

Frailty syndrome and the risk of vascular dementia: the Italian Longitudinal Study on Aging

Gene-wide analysis detects two new susceptibility genes for Alzheimer's disease

Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing

Immunotherapy for Alzheimer's disease: from anti-β-amyloid to tau-based immunization strategies.

Interleukin 6-174 G/C promoter and variable number of tandem repeats (VNTR) gene polymorphisms in sporadic Alzheimer's disease.

Is insulin resistant brain state a central feature of the metabolic-cognitive syndrome?

Is there still any hope for amyloid-based immunotherapy for Alzheimer's disease?

Late-life depression, mild cognitive impairment, and dementia: possible continuum?

Late-onset depression is associated to age-related central auditory processing disorder in an older population in Southern Italy

Lipoproteins, vascular-related genetic factors, and human longevity

Metabolic syndrome and cognitive impairment: current epidemiology and possible underlying mechanisms

Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer's disease

Monoclonal antibodies against β-amyloid (Aβ) for the treatment of Alzheimer's disease: the Aβ target at a crossroads

Neuropsychiatric Symptoms, Endophenotypes, and Syndromes in Late-Onset Alzheimer's Disease: Focus on APOE Gene.

Non-apolipoprotein E and apolipoprotein E genetics of sporadic Alzheimer's disease

Nutraceutical properties of Mediterranean diet and cognitive decline: possible underlying mechanisms.

Nutrition, frailty, and Alzheimer's disease

Peripheral antioxidant markers in mild cognitive impairment and its progression to dementia

Polymorphism C in the serotonin transporter gene in depression-free elderly patients with vascular dementia

Polymorphisms in glutathione S-transferase omega-1 gene and increased risk of sporadic Alzheimer disease

Polyunsaturated fatty acid and S-adenosylmethionine supplementation in predementia syndromes and Alzheimer's disease: a review

Postural and Balance Disorders in Patients with Parkinson's Disease: A Prospective Open-Label Feasibility Study with Two Months of Action Observation Treatment

Progresses in treating agitation: a major clinical challenge in Alzheimer's disease

REVIEW: γ-Secretase inhibitors for the treatment of Alzheimer's disease: The current state.

Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease

Relationships of Dietary Patterns, Foods, and Micro- and Macronutrients with Alzheimer's Disease and Late-Life Cognitive Disorders: A Systematic Review.

Reversible Cognitive Frailty, Dementia, and All-Cause Mortality. The Italian Longitudinal Study on Aging

Role of CLU, PICALM, and TNK1 Genotypes in Aging With and Without Alzheimer's Disease

Solanezumab for the treatment of mild-to-moderate Alzheimer's disease

Tau aggregation inhibitors: the future of Alzheimer's pharmacotherapy?

Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer's Disease

Tau-based therapeutics for Alzheimer's disease: active and passive immunotherapy

Tau-directed approaches for the treatment of Alzheimer's disease: focus on leuco-methylthioninium

The CALHM1 P86L polymorphism is a genetic modifier of age at onset in Alzheimer's disease: a meta-analysis study

The Multidimensional Prognostic Index (MPI), based on a comprehensive geriatric assessment predicts short- and long-term mortality in hospitalized older patients with dementia

The RELN Locus in Alzheimer's Disease

The RELN locus in Alzheimer's disease

The potential of solanezumab and gantenerumab to prevent Alzheimer's disease in people with inherited mutations that cause its early onset

Therapeutic intervention for Alzheimer's disease with γ-secretase inhibitors: still a viable option?

Time to test antibacterial therapy in Alzheimer's disease